Activation of protein kinase C does not participate in disruption of the blood-brain barrier to albumin during acute hypertension

William Mayhan, Sean P. Didion

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The blood-brain barrier minimizes the entry of macromolecules into brain tissue. During acute increases in arterial blood pressure, disruption of the blood-brain barrier occurs primarily in cerebral venules and veins. Mechanisms by which increases in cerebral venous pressure produce disruption of the blood-brain barrier during acute hypertension are not clear. The goal of this study was to determine the role of activation of protein kinase C in disruption of the blood-brain barrier during acute hypertension. We examined the microcirculation of the cerebrum in vivo. Permeability of the blood-brain barrier was quantitated by the formation of venular leaky sites and clearance of fluorescent-labeled albumin (FITC-albumin) before and during phenylephrine-induced acute hypertension. In addition, we examined changes in pial arteriolar and pial venular pressure before and during phenylephrine-induced acute hypertension. We compared responses of the blood-brain barrier to acute hypertension in control (untreated) rats and in rats treated with inhibitors of protein kinse C; calphostin C (0.1 μM) or sphingosine (1.0 μM). Under control conditions, no venular leaky sites were visible and clearance of FITC-albumin was minimal in all groups. Phenylephrine infusion increased systemic arterial, pial arteriolar and pial venular pressures, and increased the formation of venular leaky sites and clearance of FITC-albumin by a similar magnitude in all groups. The findings of the present study suggest that inhibition of protein kinase C does not significantly alter the formation of venular leaky sites and/or clearance of FITC-albumin during acute hypertension. Thus, disruption of the blood-brain barrier during acute hypertension does not appear to be influenced by activation of protein kinase C.

Original languageEnglish (US)
Pages (from-to)106-112
Number of pages7
JournalBrain Research
Volume696
Issue number1-2
DOIs
StatePublished - Oct 23 1995

Fingerprint

Blood-Brain Barrier
Protein Kinase C
Albumins
Hypertension
Phenylephrine
Cerebral Veins
Pressure
Sphingosine
Venous Pressure
Venules
Protein C Inhibitor
Cerebrum
Microcirculation
Permeability
Arterial Pressure
FITC-albumin
Brain

Keywords

  • Brain
  • Calphostin C
  • Cerebral venule
  • FITC-albumin
  • Rat
  • Sphingosine
  • Vascular permeability
  • Venular pressure

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Developmental Biology
  • Clinical Neurology

Cite this

Activation of protein kinase C does not participate in disruption of the blood-brain barrier to albumin during acute hypertension. / Mayhan, William; Didion, Sean P.

In: Brain Research, Vol. 696, No. 1-2, 23.10.1995, p. 106-112.

Research output: Contribution to journalArticle

@article{0a1ad4827d76425296df6bd8421564b7,
title = "Activation of protein kinase C does not participate in disruption of the blood-brain barrier to albumin during acute hypertension",
abstract = "The blood-brain barrier minimizes the entry of macromolecules into brain tissue. During acute increases in arterial blood pressure, disruption of the blood-brain barrier occurs primarily in cerebral venules and veins. Mechanisms by which increases in cerebral venous pressure produce disruption of the blood-brain barrier during acute hypertension are not clear. The goal of this study was to determine the role of activation of protein kinase C in disruption of the blood-brain barrier during acute hypertension. We examined the microcirculation of the cerebrum in vivo. Permeability of the blood-brain barrier was quantitated by the formation of venular leaky sites and clearance of fluorescent-labeled albumin (FITC-albumin) before and during phenylephrine-induced acute hypertension. In addition, we examined changes in pial arteriolar and pial venular pressure before and during phenylephrine-induced acute hypertension. We compared responses of the blood-brain barrier to acute hypertension in control (untreated) rats and in rats treated with inhibitors of protein kinse C; calphostin C (0.1 μM) or sphingosine (1.0 μM). Under control conditions, no venular leaky sites were visible and clearance of FITC-albumin was minimal in all groups. Phenylephrine infusion increased systemic arterial, pial arteriolar and pial venular pressures, and increased the formation of venular leaky sites and clearance of FITC-albumin by a similar magnitude in all groups. The findings of the present study suggest that inhibition of protein kinase C does not significantly alter the formation of venular leaky sites and/or clearance of FITC-albumin during acute hypertension. Thus, disruption of the blood-brain barrier during acute hypertension does not appear to be influenced by activation of protein kinase C.",
keywords = "Brain, Calphostin C, Cerebral venule, FITC-albumin, Rat, Sphingosine, Vascular permeability, Venular pressure",
author = "William Mayhan and Didion, {Sean P.}",
year = "1995",
month = "10",
day = "23",
doi = "10.1016/0006-8993(95)00782-L",
language = "English (US)",
volume = "696",
pages = "106--112",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Activation of protein kinase C does not participate in disruption of the blood-brain barrier to albumin during acute hypertension

AU - Mayhan, William

AU - Didion, Sean P.

PY - 1995/10/23

Y1 - 1995/10/23

N2 - The blood-brain barrier minimizes the entry of macromolecules into brain tissue. During acute increases in arterial blood pressure, disruption of the blood-brain barrier occurs primarily in cerebral venules and veins. Mechanisms by which increases in cerebral venous pressure produce disruption of the blood-brain barrier during acute hypertension are not clear. The goal of this study was to determine the role of activation of protein kinase C in disruption of the blood-brain barrier during acute hypertension. We examined the microcirculation of the cerebrum in vivo. Permeability of the blood-brain barrier was quantitated by the formation of venular leaky sites and clearance of fluorescent-labeled albumin (FITC-albumin) before and during phenylephrine-induced acute hypertension. In addition, we examined changes in pial arteriolar and pial venular pressure before and during phenylephrine-induced acute hypertension. We compared responses of the blood-brain barrier to acute hypertension in control (untreated) rats and in rats treated with inhibitors of protein kinse C; calphostin C (0.1 μM) or sphingosine (1.0 μM). Under control conditions, no venular leaky sites were visible and clearance of FITC-albumin was minimal in all groups. Phenylephrine infusion increased systemic arterial, pial arteriolar and pial venular pressures, and increased the formation of venular leaky sites and clearance of FITC-albumin by a similar magnitude in all groups. The findings of the present study suggest that inhibition of protein kinase C does not significantly alter the formation of venular leaky sites and/or clearance of FITC-albumin during acute hypertension. Thus, disruption of the blood-brain barrier during acute hypertension does not appear to be influenced by activation of protein kinase C.

AB - The blood-brain barrier minimizes the entry of macromolecules into brain tissue. During acute increases in arterial blood pressure, disruption of the blood-brain barrier occurs primarily in cerebral venules and veins. Mechanisms by which increases in cerebral venous pressure produce disruption of the blood-brain barrier during acute hypertension are not clear. The goal of this study was to determine the role of activation of protein kinase C in disruption of the blood-brain barrier during acute hypertension. We examined the microcirculation of the cerebrum in vivo. Permeability of the blood-brain barrier was quantitated by the formation of venular leaky sites and clearance of fluorescent-labeled albumin (FITC-albumin) before and during phenylephrine-induced acute hypertension. In addition, we examined changes in pial arteriolar and pial venular pressure before and during phenylephrine-induced acute hypertension. We compared responses of the blood-brain barrier to acute hypertension in control (untreated) rats and in rats treated with inhibitors of protein kinse C; calphostin C (0.1 μM) or sphingosine (1.0 μM). Under control conditions, no venular leaky sites were visible and clearance of FITC-albumin was minimal in all groups. Phenylephrine infusion increased systemic arterial, pial arteriolar and pial venular pressures, and increased the formation of venular leaky sites and clearance of FITC-albumin by a similar magnitude in all groups. The findings of the present study suggest that inhibition of protein kinase C does not significantly alter the formation of venular leaky sites and/or clearance of FITC-albumin during acute hypertension. Thus, disruption of the blood-brain barrier during acute hypertension does not appear to be influenced by activation of protein kinase C.

KW - Brain

KW - Calphostin C

KW - Cerebral venule

KW - FITC-albumin

KW - Rat

KW - Sphingosine

KW - Vascular permeability

KW - Venular pressure

UR - http://www.scopus.com/inward/record.url?scp=0028866441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028866441&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(95)00782-L

DO - 10.1016/0006-8993(95)00782-L

M3 - Article

VL - 696

SP - 106

EP - 112

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -